IN2012DN01577A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01577A
IN2012DN01577A IN1577DEN2012A IN2012DN01577A IN 2012DN01577 A IN2012DN01577 A IN 2012DN01577A IN 1577DEN2012 A IN1577DEN2012 A IN 1577DEN2012A IN 2012DN01577 A IN2012DN01577 A IN 2012DN01577A
Authority
IN
India
Prior art keywords
relates
present
attenuated
cells
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Marigliano Martine
Reymund Jacqueline
Sainte-Marie Martine
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of IN2012DN01577A publication Critical patent/IN2012DN01577A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN1577DEN2012 2009-07-21 2010-07-21 IN2012DN01577A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09305690 2009-07-21
US26429909P 2009-11-25 2009-11-25
PCT/EP2010/004478 WO2011009613A1 (en) 2009-07-21 2010-07-21 Enzymatic composition for the digestion of chicken embryos

Publications (1)

Publication Number Publication Date
IN2012DN01577A true IN2012DN01577A (zh) 2015-06-05

Family

ID=43498784

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1577DEN2012 IN2012DN01577A (zh) 2009-07-21 2010-07-21

Country Status (13)

Country Link
US (1) US20120190100A1 (zh)
EP (1) EP2456461A1 (zh)
JP (1) JP2012533311A (zh)
KR (1) KR20120089245A (zh)
CN (1) CN102939100A (zh)
AU (1) AU2010275764A1 (zh)
CA (1) CA2768562A1 (zh)
IN (1) IN2012DN01577A (zh)
MX (1) MX2012000979A (zh)
RU (1) RU2012106760A (zh)
SG (1) SG178090A1 (zh)
TW (1) TW201109440A (zh)
WO (1) WO2011009613A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120264920A1 (en) * 2010-10-11 2012-10-18 Abbott Laboratories Processes for purification of proteins
WO2014009276A1 (en) 2012-07-09 2014-01-16 Roche Diagnostics Gmbh Recombinantly produced neutral protease originating from paenibacillus polymyxa
CN104818238B (zh) * 2015-03-26 2019-12-20 四川农业大学 一种鸡肠上皮细胞分离培养方法
PL3298139T3 (pl) 2015-05-19 2022-01-31 Scientific Protein Laboratories Llc Sposób zmniejszenia lub inaktywacji zawartości wirusów i drobnoustrojów w sposobach wytwarzania pankreatyny
CN105316309A (zh) * 2015-12-04 2016-02-10 广州赛莱拉干细胞科技股份有限公司 一种消化酶组合物及成纤维细胞和饲养层细胞的制备方法
CN109957545A (zh) 2017-12-26 2019-07-02 江苏艾尔康生物医药科技有限公司 一种消化rpe细胞的方法
CN111936622B (zh) * 2018-01-19 2024-05-28 可隆生命科学株式会社 重组痘苗病毒和包含其的药物组合物
WO2019212921A1 (en) * 2018-04-29 2019-11-07 Regenxbio Inc. Scalable clarification process for recombinant aav production
CN115927162A (zh) * 2019-03-08 2023-04-07 中国人民解放军军事科学院军事医学研究院 汗腺细胞的培养获得汗腺类器官的方法及其应用
CN111117947B (zh) * 2020-01-09 2022-03-08 电子科技大学 一种鲤科鱼类肝细胞的快速分离方法
CN112458040B (zh) * 2020-12-23 2022-07-05 四川农业大学 一种成年牦牛瘤胃上皮细胞的分离培养方法
CN113136412A (zh) * 2021-04-22 2021-07-20 浙江珂瑞康生物医疗科技有限公司 用于含可溶性蛋白生物医用材料的生物负载测定处理液

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072565A (en) * 1974-11-04 1978-02-07 The Dow Chemical Company Production of viruses in tissue culture without use of serum
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
FR2643817B1 (fr) 1989-03-06 1993-12-17 Transgene Sa Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
GB9001641D0 (en) 1990-01-24 1990-03-21 Imp Cancer Res Tech Compounds
FR2668064B1 (fr) 1990-10-23 1994-12-16 Transgene Sa Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.
WO1994029471A1 (en) 1993-06-10 1994-12-22 Genetic Therapy, Inc. Adenoviral vectors for treatment of hemophilia
FR2710536B1 (fr) 1993-09-29 1995-12-22 Transgene Sa Usage anti-cancéreux d'un vecteur viral comportant un gène modulateur de la réponse immunitaire et/ou inflammatoire.
FR2751879B1 (fr) 1996-07-30 1998-10-30 Transgene Sa Composition pharmaceutique contre les tumeurs et infections a papillomavirus
FR2766091A1 (fr) 1997-07-18 1999-01-22 Transgene Sa Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee
FR2777570A1 (fr) 1998-04-17 1999-10-22 Transgene Sa Mutant ayant une activite phosphoribosyl transferase
WO2004022729A1 (en) 2002-09-05 2004-03-18 Bavarian Nordic A/S Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
FR2855758B1 (fr) 2003-06-05 2005-07-22 Biomerieux Sa Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique
CA2532783C (en) 2003-07-21 2013-09-17 Transgene S.A. Polypeptide having an improved cytosine deaminase activity
WO2005030940A1 (en) * 2003-09-29 2005-04-07 Seong Jun Yoon Highly bioactive and productive chicken embryo extract and method for preparation thereof
CA2576872C (en) * 2004-08-13 2013-11-12 University Of Georgia Research Foundation, Inc. Compositions and methods for self-renewal and differentiation in human embryonic stem cells
WO2006052826A2 (en) * 2004-11-05 2006-05-18 The Government Of The United States Of America As Represented By The Secretary Methods for preparing cells and viruses
US20100138947A1 (en) 2005-04-29 2010-06-03 Ivan Vassiliev Method for Producing Stem Cells or Stel Cell-Like Cells from Mammalian Embryos
EP2013229A2 (en) 2006-04-21 2009-01-14 Transgene S.A. Hpv-18-based papillomavirus vaccine
RU2551982C2 (ru) 2006-06-20 2015-06-10 Трансжене С.А. Способ получения поксвирусов и композиции поксвирусов
GB0613756D0 (en) * 2006-07-12 2006-08-23 Univ Sheffield Cell culture medium

Also Published As

Publication number Publication date
TW201109440A (en) 2011-03-16
CN102939100A (zh) 2013-02-20
CA2768562A1 (en) 2011-01-27
MX2012000979A (es) 2012-06-08
US20120190100A1 (en) 2012-07-26
AU2010275764A2 (en) 2012-03-15
EP2456461A1 (en) 2012-05-30
RU2012106760A (ru) 2013-08-27
JP2012533311A (ja) 2012-12-27
SG178090A1 (en) 2012-03-29
AU2010275764A1 (en) 2012-03-15
WO2011009613A1 (en) 2011-01-27
KR20120089245A (ko) 2012-08-09

Similar Documents

Publication Publication Date Title
IN2012DN01577A (zh)
BR112013011194A2 (pt) partículas de glicoproteína semelhantes a vírus (vlps) da raiva.
CY1121159T1 (el) Μη-ενσωματουμενοι λεντiϊικοι φορεις
PH12015501953A1 (en) Substituted nucleotide analogs
CR20110641A (es) Metodo para la produccion y purificacion de orthopoxvirus
MY183385A (en) Production of polio virus at high titers for vaccine production
NZ629582A (en) Production of fmdv-resistant livestock by allele substitution
CY1114356T1 (el) Αναστολεις του ιου της ηπατιτιδας c
MXPA06013411A (es) Procedimiento para la produccion de una vacuna contra la influenza.
MX2007007889A (es) Rescate del virus de influenza.
MX349119B (es) Vacuna de virus de dengue inactivado.
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
SG179082A1 (en) Method for the preparation of an influenza virus
NZ702146A (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
WO2011007339A3 (en) Chimeric foot and mouth disease viruses
WO2009080806A3 (en) Modified influenza virus
WO2009135199A3 (en) Vaccine compositions and methods
WO2013058484A3 (ko) 인제난 타입의 디테르펜 화합물 및 이를 포함하는 바이러스 감염 질환의 치료 또는 예방용 약학적 조성물
MX2010005701A (es) Metodo para producir cepa viral vacunal de un virus de la familia reoviridae.
UA103330C2 (ru) Вакцина против инфекционного бронхита, полученная из ib-qx-подобных штаммов
WO2009126308A3 (en) Compositions and methods for vaccine and virus production
MX2011002309A (es) Anticuerpos de aves especificos para virus de influenza y metodos tecnologicamente sencillos de su fabricacion y uso.
WO2014008475A3 (en) Compositions and methods related to viral vaccines
WO2009152519A3 (en) Novel antiviral peptides against influenza virus
IN2011KN02819A (zh)